• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超出米兰标准的2-3厘米乙肝相关单发性肝细胞癌的复发:切除术与消融术的比较

Recurrence Beyond the Milan Criteria of HBV-Related Single Hepatocellular Carcinoma of 2-3 cm: Comparison of Resection and Ablation.

作者信息

Chen Shuanggang, Ma Weimei, Shen Lujun, Wu Ying, Qi Han, Cao Fei, Huang Tao, Fan Weijun

机构信息

Department of Oncology, Yuebei People's Hospital, Shantou University Medical College, Shaoguan, China.

Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.

出版信息

Front Oncol. 2021 Oct 18;11:757149. doi: 10.3389/fonc.2021.757149. eCollection 2021.

DOI:10.3389/fonc.2021.757149
PMID:34733791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8558395/
Abstract

BACKGROUND

Comparison of patterns of early hepatocellular carcinoma (HCC) recurrence beyond the Milan criteria (HRBM) and identification of the independent risk factors of time to recurrence beyond the Milan criteria (TRBM) after resection or ablation can develop an optimal first-line treatment and provide more opportunities and waiting time for salvage transplantation.

METHODS

The patterns of HRBM after first-line resection or ablation in 384 patients with single-nodule HBV-associated HCC of 2-3 cm were retrospectively analyzed by one-to-one propensity score matching (PSM) between December 2008 and December 2017. The median TRBM between the resection group and the ablation group was estimated by Kaplan-Meier curves. The Cox regression analysis and binary logistic regression were used for the identification of the independent risk factors of TRBM and the occurrence of HRBM, respectively. The abilities of HRBM and the recurrence to predict overall survival (OS) were compared by the time-dependent receiver operating characteristic curves and estimated area under the curve.

RESULTS

Of 384 patients enrolled in our study, 260 (67.7%) received resection (resection group) and 124 (32.3%) underwent ablation (ablation group). The median TRBM in the resection group was significantly longer than that in the ablation group before PSM (median, not available . 101.4 months, < 0.001) and after PSM (median, not available . 85.7 months, < 0.001). Cox regression showed ablation, older age, CRP ≥1.81 mg/L, and PLT ≤80 × 10/L were the independent risk factors of TRBM. Binary logistic regression also showed that ablation, CRP ≥1.81 mg/L, and PLT ≤80 × 10/L were the independent risk factors of the occurrence of HRBM. The incidences of various phenotypes of HRBM were not significantly different between the two groups, but the incidence of HRBM at the first recurrence in the ablation group was significantly higher than that in the resection group ( < 0.05). Besides, compared with recurrence, HRBM was a better predictor of OS ( < 0.05).

CONCLUSIONS

Compared with ablation, resection should be considered as a more appropriate first-line option for patients with single-nodule HBV-associated HCC of 2-3 cm and a more promising bridge for liver transplantation in those patients.

摘要

背景

比较米兰标准以外的早期肝细胞癌(HCC)复发模式(HRBM),并确定切除或消融术后米兰标准以外的复发时间(TRBM)的独立危险因素,可为制定最佳一线治疗方案提供依据,并为挽救性移植提供更多机会和等待时间。

方法

回顾性分析2008年12月至2017年12月期间384例2 - 3 cm单结节HBV相关HCC患者一线切除或消融术后的HRBM模式。通过一对一倾向评分匹配(PSM)进行分析。采用Kaplan-Meier曲线估计切除组和消融组的中位TRBM。分别采用Cox回归分析和二元逻辑回归确定TRBM和HRBM发生的独立危险因素。通过时间依赖性受试者工作特征曲线和曲线下面积估计比较HRBM和复发对总生存(OS)的预测能力。

结果

在本研究纳入的384例患者中,260例(67.7%)接受了切除(切除组),124例(32.3%)接受了消融(消融组)。在PSM前,切除组的中位TRBM显著长于消融组(中位值,不可用. 101.4个月,<0.001);PSM后也是如此(中位值,不可用. 85.7个月,<0.001)。Cox回归显示,消融、年龄较大、CRP≥1.81 mg/L和PLT≤80×10⁹/L是TRBM的独立危险因素。二元逻辑回归还显示,消融、CRP≥1.81 mg/L和PLT≤80×10⁹/L是HRBM发生的独立危险因素。两组间HRBM各表型的发生率无显著差异,但消融组首次复发时HRBM的发生率显著高于切除组(<0.05)。此外,与复发相比,HRBM是OS的更好预测指标(<0.05)。

结论

对于2 - 3 cm单结节HBV相关HCC患者,与消融相比,切除应被视为更合适的一线治疗选择,并且是这些患者肝移植更有前景的桥梁。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f783/8558395/7a8051894141/fonc-11-757149-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f783/8558395/50d524cefcb4/fonc-11-757149-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f783/8558395/be01a7410826/fonc-11-757149-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f783/8558395/7a8051894141/fonc-11-757149-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f783/8558395/50d524cefcb4/fonc-11-757149-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f783/8558395/be01a7410826/fonc-11-757149-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f783/8558395/7a8051894141/fonc-11-757149-g003.jpg

相似文献

1
Recurrence Beyond the Milan Criteria of HBV-Related Single Hepatocellular Carcinoma of 2-3 cm: Comparison of Resection and Ablation.超出米兰标准的2-3厘米乙肝相关单发性肝细胞癌的复发:切除术与消融术的比较
Front Oncol. 2021 Oct 18;11:757149. doi: 10.3389/fonc.2021.757149. eCollection 2021.
2
Radiofrequency ablation surgical resection in elderly patients with hepatocellular carcinoma in Milan criteria.射频消融术与手术切除治疗米兰标准老年肝细胞肝癌的疗效比较
World J Gastroenterol. 2021 May 14;27(18):2205-2218. doi: 10.3748/wjg.v27.i18.2205.
3
Single-nodule hepatitis B virus-associated hepatocellular carcinoma smaller than 3 cm: two phenotypes defined by cluster analysis and their association with the outcome of ablation as the first-line therapy.单结节乙肝病毒相关肝细胞癌,肿瘤直径小于 3cm:聚类分析定义的两种表型及其与消融作为一线治疗的结果的相关性。
Int J Hyperthermia. 2021;38(1):120-129. doi: 10.1080/02656736.2021.1876930.
4
Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis.米兰标准范围内甲胎蛋白阳性肝细胞癌的切除术与消融术比较:倾向评分分析。
Liver Int. 2016 Nov;36(11):1677-1687. doi: 10.1111/liv.13166. Epub 2016 Jun 3.
5
Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.射频消融作为潜在可移植患者小于 3cm 的肝细胞癌一线治疗的结果。
J Hepatol. 2019 May;70(5):866-873. doi: 10.1016/j.jhep.2018.12.027. Epub 2019 Jan 5.
6
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.验证 AFP 模型作为预测病毒肝炎相关性肝硬化患者 HCC 复发的指标,这些患者因 HCC 已接受肝移植。
J Hepatol. 2017 Mar;66(3):552-559. doi: 10.1016/j.jhep.2016.10.038. Epub 2016 Nov 27.
7
Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study.乙型肝炎病毒相关肝细胞癌伴门静脉高压患者的肝切除术与消融术:一项倾向评分匹配研究
Surgery. 2015 Nov;158(5):1235-43. doi: 10.1016/j.surg.2015.04.002. Epub 2015 May 7.
8
Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.乙型肝炎和丙型肝炎相关肝细胞癌手术治疗效果的差异:单一大西洋彼岸中心的回顾性分析。
Ann Surg. 2014 Oct;260(4):650-6; discussion 656-8. doi: 10.1097/SLA.0000000000000917.
9
Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.非常早期肝细胞癌手术切除与射频消融治疗的临床结局:倾向评分匹配分析。
BMC Gastroenterol. 2021 Nov 8;21(1):418. doi: 10.1186/s12876-021-01995-z.
10
Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria.对于超出米兰标准的肝细胞癌患者,肝切除术与肝切除术联合经动脉化疗栓塞术的比较
J Surg Res. 2017 Mar;209:8-16. doi: 10.1016/j.jss.2016.09.054. Epub 2016 Oct 4.

引用本文的文献

1
Long-Term Analysis of Recurrence Beyond Milan Criteria Following Ablation of Solitary Early-Stage Hepatocellular Carcinoma ≤3 cm in Potentially Transplantable Patients: A Over 10-Year Survival Study.潜在可移植患者中直径≤3cm的孤立早期肝细胞癌消融术后超出米兰标准的复发长期分析:一项超过10年的生存研究
J Hepatocell Carcinoma. 2025 Feb 3;12:205-218. doi: 10.2147/JHC.S505979. eCollection 2025.

本文引用的文献

1
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
2
Hepatocellular Carcinoma Within the Milan Criteria: A Novel Inflammation-Based Nomogram System to Assess the Outcomes of Ablation.米兰标准内的肝细胞癌:一种基于炎症的新型列线图系统,用于评估消融结果。
Front Oncol. 2020 Sep 14;10:1764. doi: 10.3389/fonc.2020.01764. eCollection 2020.
3
Radiofrequency Ablation Following Downstaging of Hepatocellular Carcinoma by Using Transarterial Chemoembolization: Long-term Outcomes.
射频消融联合经动脉化疗栓塞术降期治疗肝细胞癌:长期疗效。
Radiology. 2019 Dec;293(3):707-715. doi: 10.1148/radiol.2019181991. Epub 2019 Oct 22.
4
HBV-Induced Immune Imbalance in the Development of HCC.HBV 诱导的免疫失衡在 HCC 发展中的作用。
Front Immunol. 2019 Aug 27;10:2048. doi: 10.3389/fimmu.2019.02048. eCollection 2019.
5
C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation.C 反应蛋白是肝移植后肝细胞癌复发的独立预测因子。
PLoS One. 2019 May 29;14(5):e0216677. doi: 10.1371/journal.pone.0216677. eCollection 2019.
6
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.指南解读:肝胆肿瘤,第二版,2019 年。
J Natl Compr Canc Netw. 2019 Apr 1;17(4):302-310. doi: 10.6004/jnccn.2019.0019.
7
Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.射频消融作为潜在可移植患者小于 3cm 的肝细胞癌一线治疗的结果。
J Hepatol. 2019 May;70(5):866-873. doi: 10.1016/j.jhep.2018.12.027. Epub 2019 Jan 5.
8
Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.基于甲胎蛋白和 C 反应蛋白的血清学风险指数预测晚期肝细胞癌患者无效肝移植。
Dig Dis Sci. 2019 Jan;64(1):269-280. doi: 10.1007/s10620-018-5296-9. Epub 2018 Sep 27.
9
Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study.比较 UICC 分期 T3 期肝细胞癌的肝切除术与经肝动脉化疗栓塞术:一项倾向评分匹配研究。
BMC Cancer. 2018 Jun 7;18(1):643. doi: 10.1186/s12885-018-4557-5.
10
Radiofrequency ablation versus resection for hepatocellular carcinoma in patients with Child-Pugh A liver cirrhosis: a meta-analysis.Child-Pugh A级肝硬化患者肝细胞癌的射频消融与切除术:一项荟萃分析
Clin Radiol. 2017 Dec;72(12):1066-1075. doi: 10.1016/j.crad.2017.07.024. Epub 2017 Aug 26.